phrykt

Liquidia Corp (LQDA): who owns it and who trades it

As of Nov 16, 2026, LQDA insiders reported 171 open-market sales worth $228M and 1 purchase worth $318K in the last 12 months, with 34% of the sale value made under pre-set 10b5-1 plans. The largest seller was Stephen M Bloch (Director), with $125M. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Liquidia

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Funds and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns LQDA

335 funds and institutions reported LQDA shares worth $5.8B at the end of Q2 2026, about 82% of the company. The largest holder is BlackRock, Inc. with 12.1%.

Funds and institutions (13F) 82%Everyone else 18%

10 largest owners, by share of the company

BlackRock, Inc.12.1%
Farallon Capital Management, L.l.c.9.4%
Caligan Partners LP9.1%
Findell Capital Management LLC3.9%
Vanguard Capital Management LLC3.5%
State Street Corp3.4%
Opaleye Management Inc.2.8%
Geode Capital Management, LLC2.4%
Bank of America Corp2.2%
T. Rowe Price Associates2.2%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.10.79M12.13%$860M+97%
Farallon Capital Management, L.l.c.8.37M9.41%$667M-3%
Caligan Partners LP8.12M9.13%$647MNo change
Findell Capital Management LLC3.50M3.94%$279MNo change
Vanguard Capital Management LLC3.14M3.53%$250M+7%
State Street Corp3.03M3.41%$242M+61%
Opaleye Management Inc.2.45M2.75%$195M-4%
Geode Capital Management, LLC2.12M2.39%$169M+10%
Bank of America Corp1.99M2.24%$159M-13%
T. Rowe Price Associates1.94M2.18%$155M+104%
Vanguard Portfolio Management LLC1.53M1.72%$122M+142%
Caprock Group, LLC1.41M1.59%$112M+3%
Mpm Bioimpact LLC1.39M1.56%$111M-1%
D. E. Shaw & Co., Inc.1.27M1.43%$101M+45%
Fuller & Thaler Asset Management, Inc.1.21M1.36%$96.4M–
Goldman Sachs Group Inc958,8921.08%$76.5M+18%
Federated Hermes, Inc.816,1870.92%$65.1M+86%
Northern Trust Corp709,0630.80%$56.5M+22%
Charles Schwab Investment Management Inc674,0330.76%$53.7M+21%
Sixth Street Partners Management Company, L.P.674,0330.76%$53.7M–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, LQDA insiders reported $318K of open-market purchases and $228M of sales. 34% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$318K
1 trades, 1 people
Sales, 12 months
$228M
171 trades, 15 people
Sales under a 10b5-1 plan
34%
Share of sale value
Latest trade
Oct 26, 2026
Filed Oct 28, 2026

Purchases and sales by month

$84.6M$84.6MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Oct 26, 2026Jason AdairChief Business OfficerSale plan688$43.19$29.7KForm 4
Oct 26, 2026Dana BoyleChief Accounting OfficerSale plan1,581$43.19$68.3KForm 4
Oct 12, 2026Jason AdairChief Business OfficerSale plan7,301$28.48$208KForm 4
Oct 12, 2026Dana BoyleChief Accounting OfficerSale plan5,892$28.48$168KForm 4
Oct 12, 2026Roger JeffsCEOSale plan32,744$28.48$933KForm 4
Oct 12, 2026Michael KasetaCFOSale plan18,938$28.48$539KForm 4
Oct 12, 2026Sanjeev KhindriChief Development OfficeSale plan1,101$28.48$31.4KForm 4
Oct 12, 2026Sarah KreppChief Human Resource OffSale plan5,245$28.48$149KForm 4
Oct 12, 2026Scott MoomawChief Commercial OfficerSale plan8,863$28.48$252KForm 4
Oct 12, 2026Rajeev SaggarChief Medical OfficerSale plan9,218$28.48$263KForm 4
Oct 12, 2026Russell SchundlerGeneral CounselSale plan13,692$28.48$390KForm 4
Oct 5, 2026Stephen M BlochDirectorSale235,477$27.13$6.4MForm 4
Sep 14, 2026Raman SinghDirectorSale8,468$66.16$560KForm 4
Sep 11, 2026Raman SinghDirectorSale9,024$68.62$619KForm 4
Sep 1, 2026Sarah KreppChief Human Resource OffSale plan274$67.76$18.6KForm 4
Aug 21, 2026Jason AdairChief Business OfficerSale plan41,832$69.09$2.9MForm 4
Aug 21, 2026Jason AdairChief Business OfficerSale plan31,799$69.09$2.2MForm 4
Aug 20, 2026Katherine Rielly-GauvinDirectorSale plan18,393$72.23$1.3MForm 4
Aug 19, 2026Katherine Rielly-GauvinDirectorSale plan36,789$74.99$2.8MForm 4
Aug 19, 2026Rajeev SaggarChief Medical OfficerSale50,000$74.06$3.7MForm 4
Aug 17, 2026Rajeev SaggarChief Medical OfficerSale29,534$76.84$2.3MForm 4
Jul 27, 2026Dana BoyleChief Accounting OfficerSale plan1,600$87.53$140KForm 4
Jul 27, 2026Jason AdairChief Business OfficerSale plan688$87.53$60.2KForm 4
Jul 23, 2026Stephen M BlochDirectorSale3,600$90.71$327KForm 4
Jul 23, 2026Stephen M BlochDirectorSale96,400$89.44$8.6MForm 4
Jul 22, 2026Stephen M BlochDirectorSale37,406$87.70$3.3MForm 4
Jul 22, 2026Stephen M BlochDirectorSale48,032$88.65$4.3MForm 4
Jul 22, 2026Stephen M BlochDirectorSale14,562$89.24$1.3MForm 4
Jul 21, 2026Stephen M BlochDirectorSale556$80.66$44.8KForm 4
Jul 21, 2026Stephen M BlochDirectorSale74,444$79.98$6MForm 4
Jul 20, 2026Stephen M BlochDirectorSale3,596$79.55$286KForm 4
Jul 13, 2026Sarah KreppChief Human Resource OffSale plan558$71.39$39.8KForm 4
Jul 13, 2026Sarah KreppChief Human Resource OffSale plan7,306$71.52$523KForm 4
Jul 13, 2026Sanjeev KhindriChief Development OfficeSale plan84$71.39$6KForm 4
Jul 13, 2026Sanjeev KhindriChief Development OfficeSale plan1,101$71.52$78.7KForm 4
Jul 13, 2026Michael KasetaCFOSale plan1,453$71.39$104KForm 4
Jul 13, 2026Michael KasetaCFOSale plan18,977$71.52$1.4MForm 4
Jul 13, 2026Roger JeffsCEOSale plan32,744$71.52$2.3MForm 4
Jul 13, 2026Roger JeffsCEOSale plan2,505$71.39$179KForm 4
Jul 13, 2026Jason AdairChief Business OfficerSale plan562$71.39$40.1KForm 4
Jul 13, 2026Jason AdairChief Business OfficerSale plan7,301$71.52$522KForm 4
Jul 13, 2026Russell SchundlerGeneral CounselSale plan13,692$71.52$979KForm 4
Jul 13, 2026Russell SchundlerGeneral CounselSale plan1,046$71.39$74.7KForm 4
Jul 13, 2026Rajeev SaggarChief Medical OfficerSale plan9,223$71.52$660KForm 4
Jul 13, 2026Rajeev SaggarChief Medical OfficerSale plan703$71.39$50.2KForm 4
Jul 13, 2026Scott MoomawChief Commercial OfficerSale plan675$71.39$48.2KForm 4
Jul 13, 2026Scott MoomawChief Commercial OfficerSale plan8,864$71.52$634KForm 4
Jul 13, 2026Dana BoyleChief Accounting OfficerSale plan8,361$71.52$598KForm 4
Jul 13, 2026Dana BoyleChief Accounting OfficerSale plan641$71.39$45.8KForm 4
Jul 7, 2026Stephen M BlochDirectorSale27,282$81.31$2.2MForm 4
Jul 7, 2026Stephen M BlochDirectorSale22,718$80.48$1.8MForm 4
Jul 6, 2026Stephen M BlochDirectorSale25,000$80.18$2MForm 4
Jul 1, 2026Stephen M BlochDirectorSale24,147$79.45$1.9MForm 4
Jul 1, 2026Stephen M BlochDirectorSale853$80.05$68.3KForm 4
Jun 22, 2026Stephen M BlochDirectorSale69,500$75.54$5.3MForm 4
Jun 22, 2026Stephen M BlochDirectorSale30,500$76.18$2.3MForm 4
Jun 15, 2026Stephen M BlochDirectorSale82,740$71.42$5.9MForm 4
Jun 15, 2026Stephen M BlochDirectorSale2,322$72.08$167KForm 4
Jun 12, 2026Stephen M BlochDirectorSale13,095$72.15$945KForm 4
Jun 12, 2026Stephen M BlochDirectorSale97,954$71.37$7MForm 4
Jun 11, 2026Sarah KreppChief Human Resource OffSale plan19,131$70.28$1.3MForm 4
Jun 11, 2026Sarah KreppChief Human Resource OffSale plan5,749$70.28$404KForm 4
Jun 11, 2026Stephen M BlochDirectorSale686$72.41$49.7KForm 4
Jun 11, 2026Stephen M BlochDirectorSale92,128$71.74$6.6MForm 4
Jun 11, 2026Stephen M BlochDirectorSale20,208$71.07$1.4MForm 4
Jun 11, 2026Stephen M BlochDirectorSale85,285$69.87$6MForm 4
Jun 11, 2026Stephen M BlochDirectorSale25,117$68.91$1.7MForm 4
Jun 11, 2026Stephen M BlochDirectorSale17,369$67.90$1.2MForm 4
Jun 11, 2026Stephen M BlochDirectorSale1,476$66.40$98KForm 4
Jun 10, 2026Stephen M BlochDirectorSale14,416$64.48$930KForm 4
Jun 10, 2026Stephen M BlochDirectorSale103,301$65.54$6.8MForm 4
Jun 10, 2026Stephen M BlochDirectorSale28,237$66.30$1.9MForm 4
Jun 9, 2026Stephen M BlochDirectorSale8,034$65.24$524KForm 4
Jun 9, 2026Stephen M BlochDirectorSale64,500$64.27$4.1MForm 4
Jun 8, 2026Sanjeev KhindriChief Development OfficeSale plan4,134$65.46$271KForm 4
Jun 8, 2026Stephen M BlochDirectorSale2,804$66.19$186KForm 4
Jun 8, 2026Stephen M BlochDirectorSale106,310$64.49$6.9MForm 4
Jun 8, 2026Stephen M BlochDirectorSale39,187$65.38$2.6MForm 4
Jun 5, 2026Stephen M BlochDirectorSale2,064$64.14$132KForm 4
Jun 4, 2026Paul B ManningDirectorSale19,125$62.62$1.2MForm 4
Jun 4, 2026Paul B ManningDirectorSale68,265$63.83$4.4MForm 4
Jun 4, 2026Paul B ManningDirectorSale88,487$64.28$5.7MForm 4
Jun 4, 2026Paul B ManningDirectorSale11,513$63.13$727KForm 4
Jun 4, 2026Paul B ManningDirectorSale12,610$64.42$812KForm 4
Jun 4, 2026Stephen M BlochDirectorSale1,420$66.08$93.8KForm 4
Jun 4, 2026Stephen M BlochDirectorSale35,208$65.58$2.3MForm 4
Jun 4, 2026Stephen M BlochDirectorSale46,108$64.47$3MForm 4
Jun 3, 2026Arthur S KirschDirectorSale10,000$54.80$548KForm 4
Jun 2, 2026Arthur S KirschDirectorSale5,000$56.00$280KForm 4
Jun 1, 2026Sarah KreppChief Human Resource OffSale plan276$60.87$16.8KForm 4
Jun 1, 2026Arthur S KirschDirectorSale15,000$60.22$903KForm 4
May 27, 2026Roger JeffsCEOSale plan6,428$62.18$400KForm 4
May 26, 2026Roger JeffsCEOSale plan25,000$60.38$1.5MForm 4
May 22, 2026Roger JeffsCEOSale plan25,000$61.52$1.5MForm 4
May 21, 2026Raman SinghDirectorSale29,494$60.13$1.8MForm 4
May 21, 2026Roger JeffsCEOSale plan25,000$61.13$1.5MForm 4
May 20, 2026Roger JeffsCEOSale plan25,000$61.30$1.5MForm 4
May 19, 2026David Edward Johnson +1DirectorSale5,300$59.98$318KForm 4
May 19, 2026David Edward Johnson +1DirectorPurchase5,300$59.98$318KForm 4
May 19, 2026Roger JeffsCEOSale plan25,000$58.65$1.5MForm 4

Latest 100 of 172 trades in the last 12 months.

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Stephen M BlochDirector–$125MOct 5, 2026
Roger JeffsChief Executive Officer, Director–$32.2MOct 12, 2026
Michael KasetaCFO and COO–$16.2MOct 12, 2026
Paul B ManningDirector–$12.8MJun 4, 2026
Rajeev SaggarChief Medical Officer–$9.4MOct 12, 2026
Jason AdairChief Business Officer–$7.9MOct 26, 2026
Scott MoomawChief Commercial Officer–$5.7MOct 12, 2026
Katherine Rielly-GauvinDirector–$4.1MAug 20, 2026
Sarah KreppChief Human Resource Officer–$3.8MOct 12, 2026
Raman SinghDirector–$3.7MSep 14, 2026
Russell SchundlerGeneral Counsel–$3.1MOct 12, 2026
Dana BoyleChief Accounting Officer–$1.8MOct 26, 2026
Arthur S KirschDirector–$1.7MJun 3, 2026
David Edward JohnsonDirector, 10% owner$318K$318KMay 19, 2026
Sanjeev KhindriChief Development Officer–$387KOct 12, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

LQDA short interest

High short interest. 19.4% of LQDA shares are sold short: about 1 share in 5. Over the last 12 reports the number of shares short went up 72%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 17.51M LQDA shares were sold short, 19.4% of the shares outstanding, up 1.2% from the report before. At the average daily volume of 3.31M shares, buying them all back would take about 5.3 trading days (days to cover).

Shares short, % of all shares

19.4%May 15Oct 3020.7%

Days to cover

5.3May 15Oct 3012.9

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202617.51M19.43%+1%3.31M5.3
Oct 15, 202617.30M19.33%+37%8.74M2.0
Sep 30, 202612.64M14.12%+2%3.29M3.8
Sep 15, 202612.38M13.83%+4%1.08M11.4
Aug 31, 202611.86M13.25%No change1.17M10.2
Aug 14, 202611.86M13.25%-1%1.84M6.5
Jul 31, 202611.96M13.37%-3%1.45M8.2
Jul 15, 202612.33M13.87%-6%1.34M9.2
Jun 30, 202613.18M14.82%+14%3.25M4.0
Jun 15, 202611.61M13.06%+17%2.28M5.1
May 29, 20269.96M11.20%-2%1.28M7.8
May 15, 202610.21M11.48%+3%2.07M4.9

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Liquidia company events

Liquidia filed 10 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 10, 2026.

  1. Nov 10, 2026AnnouncementThe Company updated its corporate presentation that it uses for presentations at healthcare conferences and to analysts, current stockholders, and others. Filing
  2. Oct 14, 2026AgreementLiquidia Technologies, Inc., a Delaware corporation, a wholly-owned subsidiary of Liquidia Corporation, and United Therapeutics Corporation entered into a settlement agreement regarding all ongoing litigation between the Company and UTC, including, among other matters, the resolution of pending… Filing
  3. Sep 30, 2026AnnouncementLiquidia Corporation, a Delaware corporation, issued a press release regarding the litigation filed by United Therapeutics Corporation in the U.S. District Court for the District of Delaware under the Hatch-Waxman Act concerning U.S. Patent No. 11,826,327 and the Company’s lead product, YUTREPIA ®… Filing
  4. Sep 3, 2026AnnouncementLiquidia Corporation, a Delaware corporation, issued a press release announcing that the U.S. Food and Drug Administration has granted Fast Track Designation to YUTREPIA ® (treprostinil) inhalation powder for the treatment of Raynaud’s phenomenon associated with systemic sclerosis. Filing
  5. Aug 12, 2026AnnouncementThe Company updated its corporate presentation that it uses for presentations at healthcare conferences and to analysts, current stockholders, and others. Filing
  6. Jun 17, 2026VoteReported shareholder vote results. Filing
  7. Jun 8, 2026AnnouncementLiquidia Corporation, a Delaware corporation, issued a press release announcing that it will be added to the S&P SmallCap 600® Index, effective prior to the opening of trading on June 22, 2026. Filing
  8. May 11, 2026AnnouncementThe Company updated its corporate presentation that it uses for presentations at healthcare conferences and to analysts, current stockholders, and others. Filing
  9. Mar 5, 2026ResultsReleased financial results. Filing
  10. Jan 9, 2026AnnouncementShared information with investors. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Liquidia financials

Famous investors that hold LQDA

2 of the 50 well-known investors we track reported holding LQDA in their latest 13F filing. The largest position is Jim Simons's, worth $7.3M.

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 2026242,653$7.3M0.0%+4%
Ken Griffin · Citadel AdvisorsQ3 2026240,230$7.3M0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Liquidia Corp (LQDA) stock

Who owns the most LQDA stock?

The largest reported owner of Liquidia Corp (LQDA) is BlackRock, Inc., with 12.1% of the company. In total, 335 funds and institutions reported holding LQDA at the end of Q2 2026, together about 82% of the shares. See the largest owners.

Are LQDA insiders buying or selling?

In the last 12 months, LQDA insiders reported 1 open-market purchase worth $318K and 171 sales worth $228M. The latest trade was on Oct 26, 2026. See every trade.

What is the short interest in LQDA?

As of Oct 30, 2026, 17.51M LQDA shares were sold short, 19.4% of the shares outstanding, up 1.2% from the report before. At the average daily volume of 3.31M shares, buying them all back would take about 5.3 trading days (days to cover). See the history.

Which famous investors hold LQDA?

2 of the 50 well-known investors we track reported LQDA in their latest 13F filing, including Jim Simons, Ken Griffin. The largest position is worth $7.3M. See all holders.

Executive pay

Liquidia's chief executive was paid a total of $7.7M for the year ended Dec 31, 2025, up 14% from $6.8M the year before. In the last 12 months, Liquidia's executives and directors bought $318K of stock on the open market and sold $228M.

Chief executive, total pay$7.7MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$34.9MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$2.8MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.